• Capturing Pre-Commercial-$tage Value

    Welcome to Life Science Deal Flow. Our aim here is to hold my mouse to the fire by documenting the winners (and losers) of my life science trades and strategies. The focus is on a unique opportunities presented by pre-commercial stage life science entities. Don't forget to visit and subscribe to my other site, a FREE Venture Capital and competitive intelligence dBase, OnBioVC.
  • SEARCH the Life Science Deal Flow ARCHIVE

  • business strategy life science

I am excited to learn about Taiga Biotechnologies now residing at the Colorado Science + Technology Park @ Fitzsimons. Though no news to report this is an effort to break down what they have and what they are doing. Taiga was founded to develop novel approaches for the treatment hematological diseases; including cancers, immunodeficiencies and [...]

And the fun times at CLSDF just do not stop…Congratulations go out to Julie Gelderloos, Ph.D. of Gelderloos Medical Writing, LLC for winning the CLSDF Comment T-shirt Giveaway Contest. CLSDF not only brings you the latest in life science news from Colorado and beyond but now add haute couture to the list. In fact, while [...]

The people speak and CLSDF responds! I have received feedback from a number of folks who are excited to welcome the CLSDF posts via email but have noted that the (daily) content is simply too voluminous for some inboxes. Well I am happy to announce that a work-around has been derived in the form of [...]

A few weeks back I posted (here) about the news on Array BioPharma’s (NASDAQ: ARRY) outcome for ARRY-886 and the response Wall Street was having as well as AstraZeneca (NYSE: AZN), Array’s development partner, and Schering Plough (NYSE: SGP) and their competitive oncology product, reactions . My argument was that matching standard of care as [...]

Looks like some D-luxe apartments are beginning to emerge in the sky. For the longest time the project, 21 Fitzsimons, being developed by the Pauls Corp, was spreading only horizontally, well in the blink of an eye the fourth story on some of the units are now taking shape. This project is being developed at [...]

This is a repost from BioBeers.comBioBeers is back in action and kicking off a fantastic 2008. Be sure to join us for fun and networking at the oh so chic Forest Room Five (located across I-25 from the downtown REI). We would like to feature our existing and new members on the BioBeers site so [...]

Returning to the theme of new features available on CLSDF 2.0 please note the embedded Lijit search bar located on the side-rail. So what is it you ask? Good question. Our friends at Lijit world headquarters in Boulder were googling around the web one day when suddenly the light bulb went on…What if searching on [...]

CLSDF previously highlighted Source MDx, read the post (here)…there is nothing hotter than incorporating validated biomarkers under the umbrella of personalized medicine and that is what continues to transpire at the Source MDx Boulder headquarters. An impressive list of partners and clients of Source MDx include Abbott Labs (NYSE: ABT), Amgen (NASDAQ: AMGN), Celgene (NASDAQ: [...]

The $2.9B acquisition of Pharmion (NASDAQ: PHRM) by Celgene (NASDAQ: CELG) took another step towards closing the deal as the obligatory waiting period as required by the FTC and the Antitrust Improvements Act of 1976 expired, perhaps now clearing the way for smooth sailing to inking the deal in under 120 days. This is good. [...]

Happy New Year and welcome back to CLSDF, wishing you all the best in ’08. Though it had appeared rather quiet around this blog for the last week or so the elves have remained exceedingly busy, staying up late and working hard to deploy a more satisfying user experience. Hopefully the quality of the content [...]

« Previous Page  Next Entries »

to top of page...


 
  • Search the LSDF Archive

  • Your Advert Can Go Here!

    Find out how, email: arubenstein@rnaventures.com